Nadim Rayess

Baseline Choroidal Thickness as a Predictor for Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema

Nadim Rayess, Ehsan Rahimy, Gui‐Shuang Ying et al. · American Journal of Ophthalmology · 2014 · 148 citations

Diabetic Retinopathy, Ocular Disease, Cardiovascular Disease +8

Treatment Outcomes After 3 Years in Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen

Nadim Rayess, Samuel K. Houston, Omesh P. Gupta et al. · American Journal of Ophthalmology · 2014 · 112 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept

Nadim Rayess, Ehsan Rahimy, Philip Storey et al. · American Journal of Ophthalmology · 2016 · 112 citations

Postinjection Endophthalmitis Rates, Ocular Disease, Vitreous Body +7

Incidence and clinical features of post-injection endophthalmitis according to diagnosis

Nadim Rayess, Ehsan Rahimy, Chirag P. Shah et al. · British Journal of Ophthalmology · 2015 · 62 citations

Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System

John S. Wittenborn, Traci E. Clemons, Carl D. Regillo et al. · JAMA Ophthalmology · 2017 · 48 citations · Full text